Ethical issues in developing pharmacogenetic research partnerships with American indigenous communities

B. B. Boyer, D. Dillard, E. L. Woodahl, R. Whitener, K. E. Thummel, W. Burke

Research output: Contribution to journalComment/debatepeer-review

43 Scopus citations

Abstract

Pharmacogenetic research offers the potential to improve the safety and efficacy of drug prescribing. Assuring that the benefits of this research reach indigenous and other medically underserved people is an important justice concern. First, however, a legacy of mistrust, derived from traditional research practices that disempower communities, must be overcome. Linking pharmacogenetic research to collaborative, power-sharing research partnerships provides a valuable opportunity to develop new and positive precedents for genetic research in indigenous communities.

Original languageEnglish (US)
Pages (from-to)343-345
Number of pages3
JournalClinical pharmacology and therapeutics
Volume89
Issue number3
DOIs
StatePublished - Mar 2011
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Ethical issues in developing pharmacogenetic research partnerships with American indigenous communities'. Together they form a unique fingerprint.

Cite this